- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x DNA: 1,4-dihydroxy-2-naphthoic acid(Non-covalent)
- 4 x ACT: ACETATE ION(Non-functional Binders)
ACT.2: 6 residues within 4Å:- Chain A: P.23, E.160, A.162, P.163, T.166, L.169
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:P.23
- Hydrogen bonds: A:A.162
ACT.3: 4 residues within 4Å:- Chain A: E.130, L.158
- Chain C: E.130, L.158
5 PLIP interactions:4 interactions with chain A, 1 interactions with chain C- Water bridges: A:E.130, A:E.130, A:L.158, A:L.158
- Hydrogen bonds: C:E.130
ACT.4: 5 residues within 4Å:- Chain A: T.265, V.266, A.267, P.278, L.279
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:A.267
- Salt bridges: A:R.273
ACT.5: 5 residues within 4Å:- Chain A: R.50, P.128, L.131, R.202, E.203
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:P.128, A:L.131, A:R.202
- Hydrogen bonds: A:E.203
- Salt bridges: A:R.50, A:R.127
- 8 x FMT: FORMIC ACID(Non-functional Binders)
FMT.6: 7 residues within 4Å:- Chain A: G.48, S.49, R.50, T.98, Q.138
- Ligands: AKG.8, TOG.9
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:S.49, A:R.50, A:T.98, A:Q.138
FMT.7: 4 residues within 4Å:- Chain A: Y.129, L.143
- Chain C: Y.129, L.143
No protein-ligand interaction detected (PLIP)FMT.12: 8 residues within 4Å:- Chain B: C.46, E.75, V.95, A.96, M.97, T.98, A.102, L.106
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:T.98, B:T.98
FMT.13: 4 residues within 4Å:- Chain B: T.270, I.413, V.415, R.416
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:V.415, B:R.416
FMT.16: 7 residues within 4Å:- Chain C: G.48, S.49, R.50, T.98, R.127, Q.138
- Ligands: TOG.22
4 PLIP interactions:4 interactions with chain C- Hydrogen bonds: C:S.49, C:R.50, C:R.127, C:Q.138
FMT.17: 3 residues within 4Å:- Chain C: T.299, R.419, G.420
No protein-ligand interaction detected (PLIP)FMT.18: 5 residues within 4Å:- Chain A: Y.129, L.132
- Chain C: S.153, I.154, S.155
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:S.155
FMT.19: 4 residues within 4Å:- Chain C: R.50, P.128, L.131, E.203
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:R.50, C:E.203, C:E.203
- 1 x AKG: 2-OXOGLUTARIC ACID(Non-covalent)
- 2 x TOG: 4-[3-[(4-azanyl-2-methyl-pyrimidin-5-yl)methyl]-4-methyl-5-[2-[oxidanyl(phosphonooxy)phosphoryl]oxyethyl]-1,3-thiazol-3 -ium-2-yl]-4-oxidanyl-butanoic acid(Non-covalent)
TOG.9: 32 residues within 4Å:- Chain A: P.47, G.48, E.75, T.98, T.101, A.102, N.137, Q.138
- Chain B: A.396, S.397, N.398, P.399, R.401, R.419, A.422, G.423, I.424, D.425, G.459, D.460, L.461, T.462, H.465, D.489, G.491, G.492, G.493, I.494, F.495
- Ligands: FMT.6, AKG.8, MG.10
24 PLIP interactions:4 interactions with chain A, 20 interactions with chain B- Hydrophobic interactions: A:P.47, A:T.98, B:I.424, B:I.424, B:L.461, B:F.495
- Hydrogen bonds: A:N.137, B:S.397, B:S.397, B:N.398, B:N.398, B:A.422, B:I.424, B:G.459, B:D.460, B:L.461, B:T.462, B:G.493, B:I.494
- Water bridges: A:A.102, B:T.462
- Salt bridges: B:R.401, B:R.419
- pi-Stacking: B:F.495
TOG.22: 31 residues within 4Å:- Chain C: P.47, G.48, E.75, T.98, T.101, A.102, N.137, Q.138
- Chain D: A.396, S.397, N.398, P.399, R.401, R.419, A.422, G.423, I.424, D.425, G.459, D.460, L.461, T.462, H.465, D.489, G.491, G.492, G.493, I.494, F.495
- Ligands: FMT.16, MG.23
26 PLIP interactions:5 interactions with chain C, 21 interactions with chain D- Hydrophobic interactions: C:P.47, C:T.98, D:I.424, D:I.424, D:L.461
- Hydrogen bonds: C:N.137, D:S.397, D:S.397, D:N.398, D:A.422, D:I.424, D:D.460, D:D.460, D:L.461, D:T.462, D:T.462, D:G.493, D:I.494
- Water bridges: C:A.102, C:A.102, D:N.398, D:N.398, D:D.460
- Salt bridges: D:R.401, D:R.419
- pi-Stacking: D:F.495
- 2 x MG: MAGNESIUM ION(Non-covalent)
MG.10: 5 residues within 4Å:- Chain B: D.460, D.489, G.491, G.493
- Ligands: TOG.9
4 PLIP interactions:3 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:D.460, B:D.489, B:G.491, H2O.5
MG.23: 4 residues within 4Å:- Chain D: D.460, D.489, G.491
- Ligands: TOG.22
4 PLIP interactions:3 interactions with chain D, 1 Ligand-Water interactions- Metal complexes: D:D.460, D:D.489, D:G.491, H2O.14
- 1 x CL: CHLORIDE ION(Non-functional Binders)
- 1 x PGE: TRIETHYLENE GLYCOL(Non-functional Binders)
- 1 x GOL: GLYCEROL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bashiri, G. et al., Allosteric regulation of menaquinone (vitamin K2) biosynthesis in the human pathogenMycobacterium tuberculosis. J.Biol.Chem. (2020)
- Release Date
- 2020-02-19
- Peptides
- 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
DC
BD
C
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x DNA: 1,4-dihydroxy-2-naphthoic acid(Non-covalent)
- 4 x ACT: ACETATE ION(Non-functional Binders)
- 8 x FMT: FORMIC ACID(Non-functional Binders)
- 1 x AKG: 2-OXOGLUTARIC ACID(Non-covalent)
- 2 x TOG: 4-[3-[(4-azanyl-2-methyl-pyrimidin-5-yl)methyl]-4-methyl-5-[2-[oxidanyl(phosphonooxy)phosphoryl]oxyethyl]-1,3-thiazol-3 -ium-2-yl]-4-oxidanyl-butanoic acid(Non-covalent)
- 2 x MG: MAGNESIUM ION(Non-covalent)
- 1 x CL: CHLORIDE ION(Non-functional Binders)
- 1 x PGE: TRIETHYLENE GLYCOL(Non-functional Binders)
- 1 x GOL: GLYCEROL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bashiri, G. et al., Allosteric regulation of menaquinone (vitamin K2) biosynthesis in the human pathogenMycobacterium tuberculosis. J.Biol.Chem. (2020)
- Release Date
- 2020-02-19
- Peptides
- 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
DC
BD
C